What does APOTHEEK HOORNAERT do?

APOTHEEK HOORNAERT is a pharmacy in Deinze. Private Limited, started on 25 March 1988, 2 establishments.

What is the address of APOTHEEK HOORNAERT?

The registered office of APOTHEEK HOORNAERT is located at Leernsesteenweg 176, 9800 Deinze.

Is APOTHEEK HOORNAERT still active?

Yes. According to the CBE (30 October 2026) APOTHEEK HOORNAERT is active, legal situation “Normale toestand”, started on 25 March 1988.

Is APOTHEEK HOORNAERT registered on Peppol?

Yes, APOTHEEK HOORNAERT is registered on the Peppol network with ID 0208:0434296120.

What is the enterprise number of APOTHEEK HOORNAERT?

The enterprise number of APOTHEEK HOORNAERT is BE0434296120.

When was APOTHEEK HOORNAERT founded?

APOTHEEK HOORNAERT was founded on 25 March 1988.

Who are the directors of APOTHEEK HOORNAERT?

According to the 2025 annual accounts, the directors of APOTHEEK HOORNAERT are: SIGAMA BV.

Is APOTHEEK HOORNAERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 March 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did APOTHEEK HOORNAERT make in 2025?

APOTHEEK HOORNAERT posted a profit after taxes of € 42,853 in financial year 2025.

What is the revenue of APOTHEEK HOORNAERT?

As a small company, APOTHEEK HOORNAERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 228,945.

APOTHEEK HOORNAERT (Private Limited) - Deinze

Dossier APOTHEEK HOORNAERT, printed on 30 October 2026 from databakkes.be/en/0434296120/apotheek-hoornaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK HOORNAERT from Deinze, company number BE0434296120, closed financial year 2025 with a result of € 42,853 after tax. For that financial year APOTHEEK HOORNAERT recorded a gross margin of € 228,945 and equity of € 22,383. Compared with financial year 2024, the result moved from € 74,963 to € 42,853. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 22,383

▲ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 42,853

▼ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,188

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 35,000 paid out

82 % of the profit went to the shareholders, mostly to SIGAMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Vehicles and equipment

€ 9,508

▼ 63% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.7 million

▼ 10% vs 2024

€ 149,160 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 78,603

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,315

▲ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 175,084 Gross margin 2022: € 175,084 First fiscal year in the series	€ 208,248 Gross margin 2023: € 208,248 ▲ 19% vs 2022 (€ 175,084) Favourable step	€ 279,363 Gross margin 2024: € 279,363 ▲ 34% vs 2023 (€ 208,248) Favourable step	€ 228,945 Gross margin 2025: € 228,945 ▼ 18% vs 2024 (€ 279,363) Unfavourable step	▼ 18%
Profit after taxes	€ 7,905 Profit after taxes 2022: € 7,905 First fiscal year in the series	€ 22,404 Profit after taxes 2023: € 22,404 ▲ 183% vs 2022 (€ 7,905) Favourable step	€ 74,963 Profit after taxes 2024: € 74,963 ▲ 235% vs 2023 (€ 22,404) Favourable step	€ 42,853 Profit after taxes 2025: € 42,853 ▼ 43% vs 2024 (€ 74,963) Unfavourable step	▼ 43%
Equity	€ -82,837 Equity 2022: € -82,837 First fiscal year in the series	€ -60,433 Equity 2023: € -60,433 ▲ € 22,404 vs 2022 (€ -82,837) Favourable step	€ 14,530 Equity 2024: € 14,530 ▲ € 74,963 vs 2023 (€ -60,433) Favourable step	€ 22,383 Equity 2025: € 22,383 ▲ 54% vs 2024 (€ 14,530) Favourable step	▲ 54%
Total debts	€ 1,897,146 Total debts 2022: € 1,897,146 First fiscal year in the series	€ 2,135,199 Total debts 2023: € 2,135,199 ▲ 13% vs 2022 (€ 1,897,146) Unfavourable step	€ 1,998,683 Total debts 2024: € 1,998,683 ▼ 6% vs 2023 (€ 2,135,199) Favourable step	€ 1,854,694 Total debts 2025: € 1,854,694 ▼ 7% vs 2024 (€ 1,998,683) Favourable step	▼ 7%
Cash	€ 41,362 Cash 2022: € 41,362 First fiscal year in the series	€ 6,484 Cash 2023: € 6,484 ▼ 84% vs 2022 (€ 41,362) Unfavourable step	€ 12,850 Cash 2024: € 12,850 ▲ 98% vs 2023 (€ 6,484) Favourable step	€ 11,188 Cash 2025: € 11,188 ▼ 13% vs 2024 (€ 12,850) Unfavourable step	▼ 13%
Land & buildings	€ 921,026 Land & buildings 2022: € 921,026 First fiscal year in the series	€ 1,274,953 Land & buildings 2023: € 1,274,953 ▲ 38% vs 2022 (€ 921,026) Unchanged	€ 1,255,823 Land & buildings 2024: € 1,255,823 ▼ 2% vs 2023 (€ 1,274,953) Unchanged	€ 1,159,669 Land & buildings 2025: € 1,159,669 ▼ 8% vs 2024 (€ 1,255,823) Unchanged	▼ 8%
Retained profit	€ -95,237 Retained profit 2022: € -95,237 First fiscal year in the series	€ -72,833 Retained profit 2023: € -72,833 ▲ € 22,404 vs 2022 (€ -95,237) Favourable step	€ 2,130 Retained profit 2024: € 2,130 ▲ € 74,963 vs 2023 (€ -72,833) Favourable step	€ 9,983 Retained profit 2025: € 9,983 ▲ € 7,853 vs 2024 (€ 2,130) Favourable step	▲ € 7,853
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 35,000 Dividend 2025: € 35,000 Unchanged (€ 0) Unchanged
Bank debt	€ 1,030,080 Bank debt 2022: € 1,030,080 First fiscal year in the series	€ 1,962,782 Bank debt 2023: € 1,962,782 ▲ 91% vs 2022 (€ 1,030,080) Unfavourable step	€ 1,837,381 Bank debt 2024: € 1,837,381 ▼ 6% vs 2023 (€ 1,962,782) Favourable step	€ 1,661,022 Bank debt 2025: € 1,661,022 ▼ 10% vs 2024 (€ 1,837,381) Favourable step	▼ 10%
Balance sheet total	€ 1,814,309 Balance sheet total 2022: € 1,814,309 First fiscal year in the series	€ 2,074,766 Balance sheet total 2023: € 2,074,766 ▲ 14% vs 2022 (€ 1,814,309) Unchanged	€ 2,013,213 Balance sheet total 2024: € 2,013,213 ▼ 3% vs 2023 (€ 2,074,766) Unchanged	€ 1,877,077 Balance sheet total 2025: € 1,877,077 ▼ 7% vs 2024 (€ 2,013,213) Unchanged	▼ 7%
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	-	-	-

Key figures of APOTHEEK HOORNAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK HOORNAERT?

What happened at APOTHEEK HOORNAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 42,853 (▼ 43% vs 2024). Source: NBB ↗
2018 SIGAMA BV became a director. NBB
Mar 7, 2016 New establishment in Deinze. KBO
Jun 7, 1988 New establishment in Deinze. KBO
Mar 25, 1988 Start of the company according to the CBE. KBO

In short

From € 7,905 profit in 2022 to € 42,853 profit in 2025.

Paid € 15,690 in corporate taxes since 2022.

Best year ever: 2024, with € 74,963 profit.

Paid out € 35,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

SIGAMA 100%

The stake of SIGAMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK HOORNAERT

Behind APOTHEEK HOORNAERT is SIGAMA BV. The shares are held by SIGAMA (100%).

Directors

According to the 2025 annual accounts

SIGAMA BV

Director · represented by Simone Hoornaert

since 2018

Shareholders

SIGAMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Leernsesteenweg 176

9800 Deinze

2.252.859.840

Leernsesteenweg 234

9800 Deinze

Active since 7 March 2016

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SIGAMA same network

€ 12,597 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0434.296.120

VAT number

BE 0434.296.120

Registered office

Leernsesteenweg 176, 9800 Deinze

Names & denominations

APOTHEEK HOORNAERT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 March 1988

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK HOORNAERT

Financials

What happened to APOTHEEK HOORNAERT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions